Literature DB >> 1838979

ESGAB breakpoint determination: clarithromycin.

I Phillips, J Acar, F Baquero, T Bergan, A Forsgren, B Wiedemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1838979     DOI： 10.1007/bf02005466

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  2 in total

1.  Disk susceptibility testing for clarithromycin.

Authors:  J Andrews; R Wise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

2.  Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.

Authors:  P H McWhinney; S Patel; R A Whiley; J M Hardie; S H Gillespie; C C Kibbler
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.